We are live on
!
Find out more
JO
John Overdeck Two Sigma Investments
AUM
$138B
1-Year Est. Return
41.87%
John Overdeck is a co-founder of Two Sigma Investments, one of the world’s leading quantitative and technology-driven investment firms. Two Sigma applies data science, machine learning, and large-scale computing to markets across asset classes. Overdeck’s firm is a central reference point in discussions of modern systematic investing.
This Fund
S&P 500
This Quarter
Est. Return
+0.86%
1 Year Est. Return
+41.87%
3 Year Est. Return
+122.61%
5 Year Est. Return
+129.48%
10 Year Est. Return
+649.67%
AUM
$43.9B
AUM Growth
+$1.29B
(+3%)
Cap. Flow
+$573M
Cap. Flow
% of AUM
1.31%
Top 10 Holdings %
Top 10 Hldgs %
9.28%
Holding
3,471
New
479
Increased
1,205
Reduced
1,169
Closed
480
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Advanced Micro Devices
AMD
|
+$229M |
| 2 |
State Street Health Care Select Sector SPDR ETF
XLV
|
+$212M |
| 3 |
Snowflake
SNOW
|
+$211M |
| 4 |
Lam Research
LRCX
|
+$193M |
| 5 |
CME Group
CME
|
+$191M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$282M |
| 2 |
PepsiCo
PEP
|
+$239M |
| 3 |
Walmart Inc
WMT
|
+$236M |
| 4 |
General Motors
GM
|
+$223M |
| 5 |
State Street Communication Services Select Sector SPDR ETF
XLC
|
+$186M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.57% |
| 2 | Healthcare | 13.05% |
| 3 | Financials | 12.83% |
| 4 | Industrials | 10.09% |
| 5 | Consumer Discretionary | 9.66% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2701
GSI Technology
GSIT
$220M
| $182K | ﹤0.01% |
68,501
-28,334
| -29% | -$92.3K |
|
|
OGI
2702
Organigram Holdings
OGI
$178M
| $181K | ﹤0.01% |
117,613
+105,332
| +858% | +$191K |
|
2703
Zura Bio
ZURA
$604M
| $181K | ﹤0.01% |
+51,737
| New | +$211K |
|
|
ETWO
2704
DELISTED
E2open Parent Holdings
ETWO
| $179K | ﹤0.01% |
39,784
+38
| +0.1% | +$171 |
|
|
YALA
2705
Yalla Group
YALA
$841M
| $179K | ﹤0.01% |
+39,243
| New | +$186K |
|
|
VMEO
2706
DELISTED
Vimeo
VMEO
| $177K | ﹤0.01% |
47,402
-590,135
| -93% | -$2.23M |
|
|
TWOU
2707
DELISTED
2U Inc
TWOU
| $175K | ﹤0.01% |
34,146
+1,058
| +3% | +$9.17K |
|
2708
Immunic
IMUX
$225M
| $175K | ﹤0.01% |
15,754
-9,707
| -38% | -$121K |
|
2709
Epsilon Energy
EPSN
$170M
| $175K | ﹤0.01% |
32,059
-10,871
| -25% | -$58.7K |
|
|
RERE
2710
ATRenew
RERE
$906M
| $173K | ﹤0.01% |
73,116
-60,756
| -45% | -$133K |
|
2711
Intellicheck
IDN
$58.6M
| $171K | ﹤0.01% |
50,035
+39,148
| +360% | +$128K |
|
|
HITI
2712
High Tide
HITI
$216M
| $171K | ﹤0.01% |
+77,298
| New | +$180K |
|
2713
Enel Chile
ENIC
$6.27B
| $170K | ﹤0.01% |
60,883
-47,400
| -44% | -$140K |
|
2714
Bitdeer Technologies
BTDR
$2.97B
| $170K | ﹤0.01% |
16,535
+635
| +4% | +$4.35K |
|
2715
ThredUp
TDUP
$369M
| $169K | ﹤0.01% |
99,501
+42,651
| +75% | +$77.7K |
|
|
OKUR
2716
OnKure Therapeutics
OKUR
$158M
| $169K | ﹤0.01% |
11,186
-1,873
| -14% | -$31.8K |
|
2717
Harvard Bioscience
HBIO
$34.4M
| $169K | ﹤0.01% |
5,922
+1,724
| +41% | +$60.5K |
|
|
BMTX
2718
DELISTED
BM Technologies, Inc.
BMTX
| $165K | ﹤0.01% |
+73,511
| New | +$168K |
|
2719
Prelude Therapeutics
PRLD
$516M
| $164K | ﹤0.01% |
43,135
-17,462
| -29% | -$71.1K |
|
2720
VirTra
VTSI
$33.8M
| $163K | ﹤0.01% |
+21,212
| New | +$244K |
|
2721
Lantern Pharma
LTRN
$27M
| $162K | ﹤0.01% |
+34,779
| New | +$209K |
|
|
HBI
2722
DELISTED
Hanesbrands
HBI
| $161K | ﹤0.01% |
32,757
-543
| -2% | -$2.66K |
|
|
ELEV
2723
DELISTED
Elevation Oncology
ELEV
| $161K | ﹤0.01% |
+59,456
| New | +$224K |
|
|
NREF
2724
NexPoint Real Estate Finance
NREF
$332M
| $160K | ﹤0.01% |
+11,689
| New | +$158K |
|
|
AVPTW
2725
DELISTED
AvePoint Inc Warrant
AVPTW
| $160K | ﹤0.01% |
91,800
| – | – |
|
Similar funds
John Overdeck's Q2 2024 Portfolio in Review
As of Q2 2024, John Overdeck held 3,471 positions worth $43.9B, up 3% from $42.6B the previous quarter. Its ten largest holdings account for 9.3% of the portfolio.
John Overdeck's Q2 2024 filing shows 479 new, 1,205 increased, 1,169 reduced and 480 closed positions. Its largest new stake was Accenture: 270,632 shares worth $82.1M. The largest sale was Alphabet (Google) Class A, an estimated $282M.
By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 15% a quarter earlier, followed by Healthcare and Financials.
- John Overdeck's largest Q2 2024 buy was Accenture: 270,632 shares worth $82.1M.
- John Overdeck added most to Advanced Micro Devices in Q2 2024, an estimated $229M increase.
- John Overdeck's biggest Q2 2024 reduction was Alphabet (Google) Class A, cutting an estimated $282M.
- John Overdeck fully exited State Street Communication Services Select Sector SPDR ETF in Q2 2024, selling an estimated $186M.
- John Overdeck's ten largest holdings make up 9.3% of its $43.9B portfolio in Q2 2024.
- John Overdeck opened 479 new positions and closed 480 in Q2 2024.
- John Overdeck's portfolio value rose 3% quarter-over-quarter to $43.9B.
Based on Two Sigma Investments's 13F filing for Q2 2024, filed 14 Aug 2024.